| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |